These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37354829)

  • 1. Characterizing gait and exploring neuro-morphometry in patients with PSP-Richardson's syndrome and vascular parkinsonism.
    Chatterjee K; Paul S; Banerjee R; Choudhury S; Tiwari M; Basu P; Kumar H
    Parkinsonism Relat Disord; 2023 Aug; 113():105483. PubMed ID: 37354829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PSP phenotypes with survival: A brain-bank study.
    Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A; Perez-Soriano A; Sánchez-Gómez A; Garrido A; Muñoz E; Marti MJ; Valldeoriola F; Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y
    Parkinsonism Relat Disord; 2021 Mar; 84():77-81. PubMed ID: 33581485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
    Pinkhardt EH; Jürgens R; Becker W; Valdarno F; Ludolph AC; Kassubek J
    J Neurol; 2008 Dec; 255(12):1916-25. PubMed ID: 19224319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.
    Agosta F; Kostić VS; Galantucci S; Mesaros S; Svetel M; Pagani E; Stefanova E; Filippi M
    Eur J Neurosci; 2010 Aug; 32(4):640-7. PubMed ID: 20597976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain dysfunction in gait disorders of Caribbean atypical Parkinsonism and progressive supranuclear palsy patients: A comparative study.
    Welter ML; Vasseur A; Edragas R; Chaumont H; Pineau F; Mangone G; Olivier C; Leber I; Rivaud-Pechoux S; Lehericy S; Gallea C; Yahia-Cherif L; Lannuzel A
    Neuroimage Clin; 2023; 38():103443. PubMed ID: 37247501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM
    Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K; Mallien G; Bauer S; Dietzel E; Gröger A; Ebersbach G; Berg D; Maetzler W
    J Neural Transm (Vienna); 2011 Aug; 118(8):1191-7. PubMed ID: 21207078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients.
    Samotus O; Parrent A; Jog M
    J Neurol; 2021 Mar; 268(3):989-996. PubMed ID: 33011852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.
    Song J; Kim J; Lee MJ; Ahn JH; Lee DY; Youn J; Chung MJ; Kim Z; Cho JW
    Parkinsonism Relat Disord; 2022 May; 98():32-37. PubMed ID: 35447488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
    Picillo M; Ricciardi C; Tepedino MF; Abate F; Cuoco S; Carotenuto I; Erro R; Ricciardelli G; Russo M; Cesarelli M; Barone P; Amboni M
    Front Neurol; 2021; 12():674495. PubMed ID: 34177779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.